LA ASSUNZIONE DI PPI RIDUCE LA RISPOSTA ALLA TERAPIA ANTI-HCV !
Proton pump inhibitor usage reduces sustained viral response rates for veterans with HIV/HCV coinfection on ledipasvir/sofosbuvir: a real‐world study from a multicentre VA cohort Tzu‐Hao Lee et al. Abstract Previous studies have reported an association of proton pump inhibitor (PPI) use and decreased sustained viral response rate (SVR) in patients taking ledipasvir/sofosbuvir (LDV/SOF). The relationship…